2NISHIKAWA M, MYOUI A, TOMITA T, et al. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653 [ J]. Arthritis Rheum, 2003, 48 (9) : 2670 - 2681.
3CUZZOCREA S, MCDONALD M C, MOTA-FILIPE H, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis [ J ]. Arthritis Rheum, 2000, 43 (2) : 320 - 328.
4TSUBAKI T, ARITA N, KAWAKAMI T, et al. Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens [ J]. Arthritis Res Ther, 2005, 7 (4) : 825 - 836.
5BAJTNER E, NANDAKUMAR K S, ENGSTR M A, et al. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type Ⅱ collagen [J].Arthritis Res Ther, 2005, 7(5) : 1148 -1157.
6ROWLEY M J, NANDAKUMAR K S, HOLMDAHL R. The role of collagen antibodies in mediating arthritis [ J ]. Mod Rheumatol,2008, 3, [ Epub ahead of print].
7HOGG N. Free radical in disease [ J ]. Semin Reprod Endocrinol, 1998, 16(4):241-248.
8MATSUNO H, YUDOH K, KATAYAMA R,et al. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis ( RA ) : a study using a human RA/SCID mouse chimera [ J ]. Rheumatology ( Oxford), 2002, 41 ( 3 ) : 329 - 337.
